StockpollyBeta
Get App
Popularity #921
TVTX · NASDAQ · Biotechnology

Travere Therapeutics (TVTX)

Develops and sells rare kidney-disease medicines led by FILSPARI.

$60.28
After hours0.00 (0.00%)
At close$60.28(−4.10%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue37454154637582114165130127170
Cost of revenue116212235223272
Gross profit36294042617277113163127100167
128111179109117133120126138160137163
Research & development6159115545262474952585760
6853645466707376861028096
Selling & marketing0−110−1000000000
General & administrative68646465667073768610200
Other expenses000001000007
Operating income−93−83−139−67−56−61−43−1325−32−374
3−63−310101110−39
Interest income676444433333
Interest expense333333333222
Other non-operating income−63−60−4−3−4−3−4−14−237
Income before tax−89−89−136−70−55−60−41−1326−21−37−35
Income tax expense000000000100
Net income from continuing operations−89−89−136−70−55−60−41−1326−22−37−35
Discontinued operations240−20−10000025−10
Net income151−90−136−70−55−60−41−13263−37−35
EPS, basic−$0.99−$1.18−$1.76−$0.91−$0.70−$0.73−$0.47−$0.14$0.29$0.03−$0.40−$0.37
EPS, diluted−$0.99−$1.18−$1.76−$0.91−$0.70−$0.73−$0.47−$0.14$0.25$0.03−$0.40−$0.37
Weighted average shares, basic767677787883888989909293
Weighted average shares, diluted7676777878838889103909293
EBITDA−75−74−123−56−41−45−26444−1−9−33
Depreciation & amortization11121010111213141618250
EBIT−86−86−133−67−52−58−38−1028−19−34−33